CD25+ immunoregulatory T-Cells of donor origin suppress alloreactivity after BMT

Biology of Blood and Marrow Transplantation

Volumn 8, Issue 10, 2002, Pages 525-535

  Johnson, Bryon D ^a   Konkol, Marja C ^a   Truitt, Robert L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bone marrow transplantation; Donor leukocyte infusion; Graft versushost disease; Regulatory T cells

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; THY 1 ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IRRADIATION; LEUKOCYTE TRANSFUSION; LYMPHOCYTE COUNT; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; T LYMPHOCYTE; WEIGHT REDUCTION;

EID: 0036435911     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2002.v8.pm12434947     Document Type: Article

References (32)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). J Immunol. 1995;155:1151-1164.
2. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184:387-396.
3. high regulatory cells in human peripheral blood. J Immunol. 2001;167: 1245-1253.
4. + T cells with regulatory properties from human blood. J Exp Med. 2001;193: 1303-1310.
5. + T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001;193:1285-1294.
6. + T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol. 2001;31:1122-1131.
7. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999;162:5317-5326.
8. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol. 2001;31:1247-1254.
9. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000; 12:431-440.
10. Kumanogoh A, Wang X, Lee I, et al. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol. 2001;166: 353-360.
11. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18-32.
12. + suppressor T cells. Immunol Rev. 2001;182:58-67.
13. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Intl Immunol. 1998;10:1969-1980.
14. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol. 2001;166:3789-3796.
15. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med. 2001;193:1311-1317.
16. Sanchez-Fueyo A, Weber M, Domenig C, Strom TB, Zheng XX. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol. 2002;168:2274-2281.
17. 5+ subset of recent thymic emigrants. J Immunol. 2001;166:7158-7164.
18. + regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am J Respir Crit Care Med. 2001;164:680-687.
19. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res. 1999;59:3128-3133.
20. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol. 1999;163:5211-5218.
21. + T-cell-dependent immune defense of B16 melanoma. Cancer Res. 2001;61:8643-8646.
22. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality Blood. 2002;99:3493-3499.
23. Johnson BD, Becker EE, LaBelle JL, Truitt RL. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. J Immunol. 1999;163:6479-6487.
24. + regulatory cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192:303-309.
25. Rocha B, Dautigny N, Pereira P. Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/8 ratios in vivo. Eur J Immunol. 1989;19:905-911.
26. +) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI. Biol Blood Marrow Transplant. 2001;7:589-595.
27. +) T cells which promote tolerance induction and regulate autoimmunity. Immunol Rev. 1996;149:217-230.
28. Zhang Z-X, Yang L, Young KJ, DuTemple B, Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nature Med. 2000;6: 782-789.
29. + T cell as immune regulatory cell. J Mol Med. 2001;79:419-427.
30. Erard F, Wild MT, Garcia-Sanz JA, Le Gros G. Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells Science. 1993;260:1802-1805.
31. Mehal WZ, Crispe IN. TCR ligation on CD8+ T cells creates double-negative cells in vivo J Immunol. 1998;161:1686-1693.
32. Collins RH, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997;15:433-444.